Thienotriazolodiazepine compounds and pharmaceutical uses thereof
CA 1324863 C · Owner: Moriwaki, Minoru · Inventors: Tanaka, Hiroshi; Terasawa, Michio; Moriwaki, Minoru
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
A thienotriazolodiazepine compound of the formula: or a pharmaceutically acceptable salt thereof wherein, R1 is alkyl;, R2 is methyl or trifluoromethyl; R3 is phenyl or phenyl substituted by one substituent selected from the group consisting of halogen alkyl and, alkoxy;, R4 is -B1R3, In the formula -B1R5 when ? > O, R3 is hydroxy;, halogen; a group represented by -N(R11)(R12) wherein R11 and, R12 are the same or different and each is a hydrogen; straight or branched chain alkyl having 1 to 10 carbon atoms which may be substituted by amino, alkylamino dialkylamino, or cyclic amino; or R11 and R12 together with the adjacent nitrogen atom form a saturated 5- to 7-membered heterocycle selected …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Granted November 30, 1993. A Canadian patent filed before October 1, 1989 lasted 17 years from grant, so its term ended November 30, 2010.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.